Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,987
Sort by:
Daklinza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Daklinza API intelligence over Daklinza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Diabetic Retinopathy - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic retinopathy Key assessments Patient Segmentation in Diabetic retinopathy Diabetic retinopathy Risk & Burden Factors driving growth in a specific Diabetic retinopathy patient population
January 2022
60 pages
Duavee - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Duavee API intelligence over Duavee and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Dyskinesia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dyskinesia Key assessments Patient Segmentation in Dyskinesia Dyskinesia Risk & Burden Factors driving growth in a specific Dyskinesia patient population
January 2022
60 pages
Dyspepsia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dyspepsia Key assessments Patient Segmentation in Dyspepsia Dyspepsia Risk & Burden Factors driving growth in a specific Dyspepsia patient population
January 2022
60 pages
Dysport - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Dysport API intelligence over Dysport and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Endometriosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Endometriosis Key assessments Patient Segmentation in Endometriosis Endometriosis Risk & Burden Factors driving growth in a specific Endometriosis patient population
January 2022
60 pages
Entresto - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Entresto API intelligence over Entresto and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Epithelial Ovarian Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Epithelial Ovarian Cancer Key assessments Patient Segmentation in Epithelial Ovarian Cancer Epithelial Ovarian Cancer Risk & Burden Factors driving growth in a specific Epithelial Ovarian Cancer patient population
January 2022
60 pages
Epzicom - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Epzicom API intelligence over Epzicom and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Esbriet - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Esbriet API intelligence over Esbriet and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Fallopian Tube Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Fallopian Tube Cancer Key assessments Patient Segmentation in Fallopian Tube Cancer Fallopian Tube Cancer Risk & Burden Factors driving growth in a specific Fallopian Tube Cancer patient population
January 2022
60 pages
Familial Amyloid Polyneuropathy - Epidemiology Forecast to 2032
US$ 3,950.00
... (Transthyretin Amyloidosis, Corino de Andrade's Disease) Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Risk & Burden Factors driving growth in a specific Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) patient population
January 2022
60 pages
Familial Hypercholesterolemia - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Familial Hypercholesterolemia (Type II Hyperlipoproteinemia Key assessments Patient Segmentation in Familial Hypercholesterolemia (Type II Hyperlipoproteinemia Familial Hypercholesterolemia (Type II Hyperlipoproteinemia Risk ...
January 2022
60 pages
Febrile Neutropenia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Febrile Neutropenia Key assessments Patient Segmentation in Febrile Neutropenia Febrile Neutropenia Risk & Burden Factors driving growth in a specific Febrile Neutropenia patient population
January 2022
60 pages
Forteo - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Forteo API intelligence over Forteo and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gastric Ulcers - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastric Ulcers Key assessments Patient Segmentation in Gastric Ulcers Gastric Ulcers Risk & Burden Factors driving growth in a specific Gastric Ulcers patient population
January 2022
60 pages
Gastritis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastritis Key assessments Patient Segmentation in Gastritis Gastritis Risk & Burden Factors driving growth in a specific Gastritis patient population
January 2022
60 pages
Gastrointestinal Stromal Tumor (GIST) - Epidemiology Forecast to 2032
US$ 3,950.00
... 10 Year Forecast 7MM Coverage Total Cases in Gastrointestinal Stromal Tumor (GIST) Key assessments Patient Segmentation in Gastrointestinal Stromal Tumor (GIST) Gastrointestinal Stromal Tumor (GIST) Risk & Burden Factors driving growth in a specific Gastrointestinal Stromal Tumor (GIST) patient population
January 2022
60 pages
Gastroparesis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastroparesis Key assessments Patient Segmentation in Gastroparesis Gastroparesis Risk & Burden Factors driving growth in a specific Gastroparesis patient population
January 2022
60 pages
Genvoya - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Genvoya API intelligence over Genvoya and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gilvec - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Gilvec API intelligence over Gilvec and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gouty Arthritis (Gout) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gouty Arthritis (Gout) Key assessments Patient Segmentation in Gouty Arthritis (Gout) Gouty Arthritis (Gout) Risk & Burden Factors driving growth in a specific Gouty Arthritis (Gout) patient population
January 2022
60 pages
Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Graft versus host disease (GVHD) Key assessments Patient Segmentation in Graft versus host disease (GVHD) Graft versus host disease (GVHD) Risk & Burden Factors driving growth in a specific Graft versus host disease (GVHD) patient ...
January 2022
60 pages
Hairy Cell Leukemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hairy Cell Leukemia Key assessments Patient Segmentation in Hairy Cell Leukemia Hairy Cell Leukemia Risk & Burden Factors driving growth in a specific Hairy Cell Leukemia patient population
January 2022
60 pages
Harvoni - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Harvoni API intelligence over Harvoni and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Humalog - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Humalog API intelligence over Humalog and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Human Papillomavirus (HPV) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Human Papillomavirus (HPV) Key assessments Patient Segmentation in Human Papillomavirus (HPV) Human Papillomavirus (HPV) Risk & Burden Factors driving growth in a specific Human Papillomavirus (HPV) patient population
January 2022
60 pages
Humatrope - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Humatrope API intelligence over Humatrope and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Imbruvica - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Imbruvica API intelligence over Imbruvica and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Interstitial Cystitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Interstitial Cystitis Key assessments Patient Segmentation in Interstitial Cystitis Interstitial Cystitis Risk & Burden Factors driving growth in a specific Interstitial Cystitis patient population
January 2022
60 pages
Invokana - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Invokana API intelligence over Invokana and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Jardiance - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Jardiance API intelligence over Jardiance and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Jublia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Jublia API intelligence over Jublia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Kengreal - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Kengreal API intelligence over Kengreal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Lonsurf - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Lonsurf API intelligence over Lonsurf and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Lynparza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Lynparza API intelligence over Lynparza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Mekinist - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Mekinist API intelligence over Mekinist and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Narcolepsy - Epidemiology Forecast to 2032
US$ 3,950.00
... cataplexy, cases by clinical manifestation and age-specific diagnosed cases Diagnosed cases of Narcolepsy Key assessments Patient Segmentation Disease Risk & Burden Risk of disease by the segmentation Factors driving growth in a specific patient population
January 2022
60 pages
Natpara - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Natpara API intelligence over Natpara and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Northera - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Northera API intelligence over Northera and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Ofev - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Ofev API intelligence over Ofev and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Olysio - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Olysio API intelligence over Olysio and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Opsumit - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Opsumit API intelligence over Opsumit and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Osphena - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Osphena API intelligence over Osphena and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Otezla - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Otezla API intelligence over Otezla and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Parkinson's Disease - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Pipeline Analysis Parkinson's Disease Market Size and Trends Parkinson's Disease Market Opportunities Impact of upcoming Therapies in Parkinson's Disease Parkinson's Disease Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Parkinson's Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Parkinson's Disease Key assessments Patient Segmentation in Parkinson's Disease Parkinson's Disease Risk & Burden Factors driving growth in a specific Parkinson's Disease patient population
January 2022
60 pages
Peripheral T-Cell Lymphoma Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Peripheral T-Cell Lymphoma (PTCL) Key assessments Patient Segmentation in Peripheral T-Cell Lymphoma (PTCL) Peripheral T-Cell Lymphoma (PTCL) Risk & Burden Factors driving growth in a specific Peripheral T-Cell Lymphoma (PTCL ...
January 2022
60 pages
